ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,532.30
0.45%
S&P ASX All Technology
3,983.90
1.06%
Brent Oil
76.255
0.27%
US Dollar vs AUD
1.60597
-0.17%
Bitcoin
104,650.00
-0.08%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Lilly Eli and Co (LLY) Share Price

Lilly Eli and Co

Lilly Eli and Co (LLY)

Eli Lilly and Company
Eli Lilly and Co
791.10
0.00
(0.00%)
Closed 31 January 8:00AM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
791.10
Bid
792.60
Offer
794.20
Volume
0.00
0.00 Day's Range 0.00
9.6809 52 Week Range 885.00
Market Cap
751.004B
Previous Close
791.10
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,233
Shares Outstanding
949,315,694
Dividend Yield
0.79%
PE Ratio
149.13
Earnings Per Share (EPS)
5.52
Revenue
34.12B
Net Profit
5.24B

About Lilly Eli and Co

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.lilly.com
Headquarters
Indianapolis, Indiana, USA
Founded
-
Lilly Eli and Co is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker LLY. The last closing price for Lilly Eli was 791.10 €. Over the last year, Lilly Eli shares have traded in a share price range of 9.6809 € to 885.00 €.

Lilly Eli currently has 949,315,694 shares in issue. The market capitalisation of Lilly Eli is 751.00 € billion. Lilly Eli has a price to earnings ratio (PE ratio) of 149.13.

Ask ADVFN Intelligence (AI)

LLY Latest News

More News

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Feb. 25, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Eli Lilly and Company (NYSE:LLY) and Alkermes, Inc. (NASDAQ:ALKS...

26 February 2010
PR Newswire (US)

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Health Education Answers recognized as an effective online tool by eHealthcare Leadership Awards and Web Marketing Association INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- Lilly USA recently...

04 February 2010
PR Newswire (US)

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

CHICAGO, Jan. 22 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

23 January 2010
PR Newswire (US)

Lilly CEO Stresses Human Element in Driving Medical Innovation

Los Angeles Town Hall Speech Outlines Policies to Advance Medicine in New Decade LOS ANGELES, Jan. 14 /PRNewswire-FirstCall/ -- In the keynote address at a Town Hall Los Angeles luncheon event...

15 January 2010
PR Newswire (US)

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23...

24 December 2009
PR Newswire (US)

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23...

24 December 2009
PR Newswire (US)

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

NEW YORK, Dec. 10 /PRNewswire-FirstCall/ -- -- Company remains focused on speeding innovation to patients and delivering greater value to customers. -- Five strategic business units...

10 December 2009
PR Newswire (US)

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

INDIANAPOLIS, Dec. 4 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and...

05 December 2009
PR Newswire (US)

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

INDIANAPOLIS, Nov. 30 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder...

01 December 2009
PR Newswire (US)

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

Winners Can Receive Up to $15,000 Each to Donate to Nonprofit of Their Choice NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- The deadline to submit nominations for this year's Welcome Back Awards, a...

12 November 2009
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
158.17.92633015007733793.17143264767.39945459DE
435.14.64285714286756793.1688.14056738.07874014DE
12516.89096068099740.18209.68089994233740.75226705DE
2667.29.28305014505723.9876.99.68089994540773.43065538DE
52194.632.6236378877596.58859.68089995480751.43342166DE
156571.6260.410022779219.58859.68089992839646.0349282DE
260661.5510.416666667129.68859.68089992109553.78629675DE

LLY - Frequently Asked Questions (FAQ)

What is the current Lilly Eli share price?
The current share price of Lilly Eli is 791.10 €
How many Lilly Eli shares are in issue?
Lilly Eli has 949,315,694 shares in issue
What is the market cap of Lilly Eli?
The market capitalisation of Lilly Eli is EUR 751B
What is the 1 year trading range for Lilly Eli share price?
Lilly Eli has traded in the range of 9.6809 € to 885.00 € during the past year
What is the PE ratio of Lilly Eli?
The price to earnings ratio of Lilly Eli is 149.13
What is the cash to sales ratio of Lilly Eli?
The cash to sales ratio of Lilly Eli is 22.9
What is the reporting currency for Lilly Eli?
Lilly Eli reports financial results in USD
What is the latest annual turnover for Lilly Eli?
The latest annual turnover of Lilly Eli is USD 34.12B
What is the latest annual profit for Lilly Eli?
The latest annual profit of Lilly Eli is USD 5.24B
What is the registered address of Lilly Eli?
The registered address for Lilly Eli is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Lilly Eli website address?
The website address for Lilly Eli is www.lilly.com
Which industry sector does Lilly Eli operate in?
Lilly Eli operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
013CJDcom Inc
20.24 €
(0.00%)
0
013AJD.com Inc
40.65 €
(0.00%)
0
0110Thesis Gold Inc
0.428 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
20.24 €
(0.00%)
0
013AJD.com Inc
40.65 €
(0.00%)
0
0110Thesis Gold Inc
0.428 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
20.24 €
(0.00%)
0
013AJD.com Inc
40.65 €
(0.00%)
0
0110Thesis Gold Inc
0.428 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0

Discussion

View Full Feed
JusDePomme JusDePomme 8 minutes ago
#1 on breakout board today!!! Wow tomorrow gonna be fun day
AFFU
vinmantoo vinmantoo 10 minutes ago
dewphile, granted we can't really compare the L protein inhibitor from Shionogi and ENTA giving the paucity of data in the Shionogi press release. Just for an exercise let's assume they are measuring the same thing, active virus in a cell culture assay. The difference between viral reduction of 88%
ENTA
littlejohn littlejohn 11 minutes ago
Deepseek had slave labor cost or zero in

the development numbers put out

by many media sites...

Budget breakdown for Development,,,

zero labor cost for years...

zero cost for buildings and equipment...

zero cos
Top Penny Top Penny 11 minutes ago
My song to all the $$$$$$PSRU$$$$ HATERS!!!!

https://www.youtube.com/watch?v=SdJAhvTSsI4
PSRU
Huggy Bear Huggy Bear 11 minutes ago
The HMBL SCAM stock no longer has any IP.

Foote - Lucy.

IP assets - the football.

Shareholders - Charlie Brown.
HMBL
dalesio_98 dalesio_98 13 minutes ago
Lets see what I hear back:

Jan. 30, 2025 6:42 PM ET

Hello,
Please indicate if you are the Transfer Agent for BioAmber Inc (formerly BIOA, BIOAQ) CUSIP number 09072Q106 which filed for Chpt 15 and CCAA in Canada and was liquidated? Shareholders indicate Continen
GVInvestments GVInvestments 15 minutes ago
This guy does great videos on the Elon Musk Tesla scam. https://www.youtube.com/watch?v=X64CMd8ZqCo
TSLA
Top Penny Top Penny 17 minutes ago
Climbing the breakout boards, join me for a drink and a $PSRU conversation!!! Holding Tons!!!

https://www.youtube.com/watch?v=HSFsULRYxCE
PSRU
Top Penny Top Penny 26 minutes ago
Here is to .04+ friend, pour a drink!

https://www.youtube.com/watch?v=oiY_iKSpWLM
PSRU
TightCoil TightCoil 27 minutes ago
I went to bed, but had to get up and try to find out, like i heard on this board,
(a board which, by the way, everyone's idol here, Neo Se Tung, has called a "mental institution), if Queen Sandra Thompson is an assistant to Pulte, the new FHFA Director? Or otherwise, still works at the FHFA
FNMA
skitahoe skitahoe 34 minutes ago
Thanks for the reminder DJ, it pretty much lays out a lot of what we'll see in the future.

One question that really I feel uncertain about is the ability to make the improvements in DCVax-L and put it immediately into a Phase 3 trial.

In other companies when changes wer
NWBO
facts_matter14 facts_matter14 37 minutes ago
4-2-21. Can it be possible to be more wrong?????





https://investorshub.advfn.com/uimage/uploads/2025/1/31/qutyxIMG_6318.jpeg







.
SRMX
USVIHI22 USVIHI22 38 minutes ago
Im in this at .0001. Double or nothing.
GRLF
alwaysthankfull alwaysthankfull 39 minutes ago
A formal application to rename BNCM to DELEX and update the ticker symbol will be applied from Q1 2025, aligning with the new direction of the merged company. This rebrand reflects the company’s ambition to further solidify its presence in the global healthcare market and prepare for an exciting pha
BNCM
USVIHI22 USVIHI22 43 minutes ago
This stock is so last year. Good luck. For me the party is over.
ILST
Top Penny Top Penny 45 minutes ago
Oh yes shorty was wrong, thanks in advance! https://investorshub.advfn.com/uimage/uploads/2016/1/26/hubmx4.gif
PSRU
wagner wagner 48 minutes ago
Right I lost the bet yesterday and would be happier when we will see 3,4,5 bucks...

Material news February can do some magic 
NB
KILLAZILLA KILLAZILLA 51 minutes ago
LOLOLOLOL...where I live, in a rural area of Vegas (on the outskirts), exit right before Mt. Charleston (Lee Canyon), there's Raven's.

Probably one of the most intelligent birds.They resemble a crow, only much larger. I can 100% confirm that they LOVE trash....as I witnessed them pic
RDAR
weedtrader420 weedtrader420 54 minutes ago
BITCOIN 🥴📉🖌️📈🖍️😵‍💫📱 Cross Eyed Mary $140,000 no chart needed
BTCUSD
Bizreader Bizreader 55 minutes ago
"Bite me." See, where this goes is - No you bite me..."#$@." So that's as helpful as the other BS. So obviously, a few people are here are NOT here to help, they're just here to BS themselves. Oh, and they're banding together: so it's here are some documents which I believe firmly are assuring us of
COOP

Your Recent History

TG
LLY
Lilly Eli
NASDAQ
BPYPN
Brookfield Property Part...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads